JP2014504258A5 - - Google Patents

Download PDF

Info

Publication number
JP2014504258A5
JP2014504258A5 JP2013533912A JP2013533912A JP2014504258A5 JP 2014504258 A5 JP2014504258 A5 JP 2014504258A5 JP 2013533912 A JP2013533912 A JP 2013533912A JP 2013533912 A JP2013533912 A JP 2013533912A JP 2014504258 A5 JP2014504258 A5 JP 2014504258A5
Authority
JP
Japan
Prior art keywords
bond
carbon atoms
carbonyl
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013533912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014504258A (ja
Filing date
Publication date
Priority claimed from US12/902,310 external-priority patent/US20110082158A1/en
Application filed filed Critical
Publication of JP2014504258A publication Critical patent/JP2014504258A/ja
Publication of JP2014504258A5 publication Critical patent/JP2014504258A5/ja
Pending legal-status Critical Current

Links

JP2013533912A 2010-10-12 2011-10-10 選択的プロトン共役葉酸輸送体および葉酸受容体ならびにGARFTaseおよび/または他の葉酸代謝酵素のインヒビター化合物、ならびにその使用方法 Pending JP2014504258A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/902,310 2010-10-12
US12/902,310 US20110082158A1 (en) 2008-10-01 2010-10-12 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same
PCT/US2011/055584 WO2012051105A2 (en) 2010-10-12 2011-10-10 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same

Publications (2)

Publication Number Publication Date
JP2014504258A JP2014504258A (ja) 2014-02-20
JP2014504258A5 true JP2014504258A5 (cg-RX-API-DMAC7.html) 2014-11-27

Family

ID=45938910

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013533912A Pending JP2014504258A (ja) 2010-10-12 2011-10-10 選択的プロトン共役葉酸輸送体および葉酸受容体ならびにGARFTaseおよび/または他の葉酸代謝酵素のインヒビター化合物、ならびにその使用方法

Country Status (5)

Country Link
US (1) US20110082158A1 (cg-RX-API-DMAC7.html)
EP (1) EP2627332A4 (cg-RX-API-DMAC7.html)
JP (1) JP2014504258A (cg-RX-API-DMAC7.html)
CA (1) CA2813743C (cg-RX-API-DMAC7.html)
WO (1) WO2012051105A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016089879A1 (en) * 2014-12-01 2016-06-09 Endocyte, Inc. Conjugates of garftase inhibitors
ES2718175T3 (es) * 2014-12-02 2019-06-28 Lilly Co Eli Compuestos de 1-oxo-1,2-dihidroisoquinolin-7-il-(tiofen-2-il-5-sustituido)-sulfonamida, formulaciones que contienen esos compuestos, y su uso como inhibidores de AICARFT en el tratamiento de cánceres
TWI698436B (zh) 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
MA41291A (fr) 2014-12-30 2017-11-07 Forma Therapeutics Inc Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
HK1248221A1 (zh) 2015-02-05 2018-10-12 Forma Therapeutics, Inc. 异噻唑啉酮类,吡唑并嘧啶酮类和吡咯并嘧啶酮作为泛蛋白特异性蛋白酶7抑制剂
EP3253765A1 (en) 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
EP3253738A1 (en) 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920702621A (ko) * 1989-06-13 1992-10-06 스튜어트 알. 슈터 단핵세포 및/또는 마크로파지에 의한 인터루킨-1 또는 종양회사인자 생성의 억제
JPH03173890A (ja) * 1989-09-21 1991-07-29 Takeda Chem Ind Ltd ピロロ[2,3―d]ピリミジン誘導体,その製造法,用途及び中間体
US5028608A (en) * 1989-12-11 1991-07-02 The Trustees Of Princeton University N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
US5248775A (en) * 1989-12-11 1993-09-28 The Trustees Of Princeton University Pyrrolo(2,3-d)pyrimidines
JPH04117381A (ja) * 1989-12-20 1992-04-17 Takeda Chem Ind Ltd 縮合複素環化合物,その製造法,用途及び中間体
JPH0578362A (ja) * 1990-01-16 1993-03-30 Takeda Chem Ind Ltd 縮合複素環化合物,その製造法,用途及び中間体
EP0438261A3 (en) * 1990-01-16 1992-02-26 Takeda Chemical Industries, Ltd. Condensed heterocyclic glutamic acid derivatives, their production and use
US5939420A (en) * 1991-04-08 1999-08-17 Duquesne University Of The Holy Ghost Pyrrolo 2,3d!derivatives
JP3144903B2 (ja) * 1991-08-21 2001-03-12 エーザイ株式会社 縮合ピリミジン誘導体
JPH06172358A (ja) * 1991-12-27 1994-06-21 Takeda Chem Ind Ltd 縮合ピリミジン誘導体、その製造法および用途
EP0923287A4 (en) * 1996-08-30 2001-08-01 Lilly Co Eli NON-CLASSIC PYRROLO (2,3-D) PYRIMIDINE ANTIFOLATE
ES2207277T3 (es) * 1998-09-04 2004-05-16 Agouron Pharmaceuticals, Inc. Compuestos utiles como inhibidores de aircraft.
EP1424336A4 (en) * 2001-09-03 2004-11-10 Takeda Chemical Industries Ltd 1,3-BENZOTHIAZINE DERIVATIVES AND THEIR USE
US20040096436A1 (en) * 2002-08-02 2004-05-20 Regents Of The University Of California Methods for inhibiting protein kinases in cancer cells
US20050153989A1 (en) * 2004-01-13 2005-07-14 Ambit Biosciences Corporation Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
US8030319B2 (en) * 2005-02-10 2011-10-04 Duquesne University Of The Holy Ghost Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidines
CN101195625A (zh) * 2007-12-06 2008-06-11 上海交通大学 用于抗肿瘤药物抗叶酸剂及其盐和中间体
US8252804B2 (en) * 2008-10-01 2012-08-28 Duquesne University Of The Holy Spirit Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same

Similar Documents

Publication Publication Date Title
AU2022204166C1 (en) 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
AU2011302344B2 (en) HSP90 inhibitors for treating non-small cell lung cancers in wild-type EGFR and/or KRAS patients
JP2021525781A (ja) 核輸送モジュレーターとしての化合物およびその使用
JP7328323B2 (ja) SMARCA2/BRM ATPase阻害剤としての尿素化合物及び組成物
JP2016514718A5 (cg-RX-API-DMAC7.html)
JP2016526540A5 (cg-RX-API-DMAC7.html)
CA2904794A1 (en) Modulators of the eif2alpha pathway
CA2840986A1 (en) Treating cancer with hsp90 inhibitory compounds
DK2979700T3 (en) ANTITUMUM AGENT CONTAINING A LOW IRINOTECAN HYDROCHLORIDE HYDRATE
WO2006095906A1 (ja) 複素環式化合物を有効成分とする免疫抑制剤及び抗腫瘍剤
WO2016204193A1 (ja) 抗がん剤
JP2014517042A (ja) ベンダムスチンおよび/またはリツキシマブと共にピリドピリミジノンpi3k/mtor阻害剤を使用する、悪性血液疾患を治療するための併用療法
JP2012504631A5 (cg-RX-API-DMAC7.html)
TW201733580A (zh) Trk抑制劑抵抗性的癌治療劑
KR20150038466A (ko) 다이옥시노- 및 옥사진-[2,3-d]피리미딘 pi3k 억제제 화합물 및 사용 방법
US20240336606A1 (en) Substituted benzo or pyridopyrimidine amine inhibitor, preparation method therefor, and application thereof
CN103764130A (zh) 用于治疗骨癌或者预防原发性癌细胞转移性播散入骨中的pi3k抑制剂
TW201139421A (en) Novel ep4 agonist
WO2024133605A1 (en) Substituted 3,7-dihydro-1 h-purine-2,6-diones and use thereof
CN107708700A (zh) 用于治疗癌症的方法
TW201840314A (zh) Axl抑制劑與egfr酪胺酸激酶抑制藥的倂用治療法
US12558345B2 (en) CHK1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas
US20180098959A1 (en) Methods for treating cancer
JP2008542242A5 (cg-RX-API-DMAC7.html)
WO2021127305A1 (en) Methods and compositions for inducing apoptosis in cancer stem cells